{"schema_version":"secwatch.filing_event.v1","accession":"0001798749-24-000003","form_type":"8-K","ticker":"JBIO","cik":"0001798749","company_name":"Jade Biosciences, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.569792+00:00","generated_at":"2026-06-07T02:29:25.723121+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Aerovate furnishes corporate presentation with no new material facts disclosed","bullets":["Corporate presentation filed as Exhibit 99.1; no updated financial or clinical data provided.","Presentation reiterates focus on AV-101 for pulmonary arterial hypertension.","Filing is routine Regulation FD disclosure; no guidance or milestone changes announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001798749-24-000003","json":"https://secwatch.observer/filing/0001798749-24-000003.json","markdown":"https://secwatch.observer/filing/0001798749-24-000003.md","text":"https://secwatch.observer/filing/0001798749-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1798749/000179874924000003/0001798749-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1798749/000179874924000003/tmb-20240108x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:29:25.723121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}